MKMohammad H. Khan

Mohammad H. Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad H. Khan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Features of Multidrug-Resistant Gram-Negative Bacteremia: A Comparative Study of Cancer and Non-Cancer Patients

    by Destyn Dicharry, Deborah G. Smith, Muhammad H. Khan, Michelle Self, Cameron Parikh, Alexandre E. Malek

    Multidrug-resistant Gram-negative bacteremia (MDR-GNB) is a significant health threat associated with increased morbidity and mortality rates. Patients with cancer are particularly vulnerable to MDR-GNB due to immunosuppression and frequent healthcare exposure. The aim of this study was to evaluate risk factors, 30-day mortality, and outcomes in cancer and non-cancer patients. We conducted a retrospective study of adult patients aged 18 years or older with MDR-GNB who were hospitalized at Ochsner LSU Health—Academic Medical Center between January 2018 and July 2022. We collected data about demographics, comorbidities, cancer diagnosis, causative organisms, infection source, antibiotic therapy, and clinical outcomes. A total of 112 patients with MDR-GNB were included, where 31 patients (27.7%) had cancer and 81 patients (72.3%) did not. Cancer patients were more frequently male and white (74.2% vs. 58.0%, p = 0.114 and 45.2% vs. 25.9%, p = 0.031). Diabetes mellitus was more common in non-cancer patients, but it was associated with increased mortality risk in the cancer group (OR = 2.39, 95% CI: 1.125–5.074). Enterobacteriaceae species were the most frequently isolated organisms (83.0%), with no significant difference between groups. The most common source of infection was genitourinary (49.1%). ICU admission was more frequent in non-cancer patients (49.4% vs. 25.8%, p = 0.024). However, cancer patients had a higher ICU admission mortality risk (OR 2.156, 95% CI: 1.058–4.395) and recent hospitalization rates (67.7% vs. 40.7%, p = 0.011), both associated with increased mortality risk. Cancer patients had a significantly higher 30-day mortality rate (39.0% vs. 16.4%, p = 0.017; OR = 3.012, 95% CI: 1.190–7.622) and hospice admissions (22.6% vs. 3.7%, p = 0.002; OR = 7.583, 95% CI: 1.819–31.618). These findings emphasize the urgent need for early microbiological identification, targeted antimicrobial therapy, and improved infection control strategies. Given the rising prevalence of MDR-GNB pathogens, future research is needed for prompt appropriate antibacterial therapy based on risk stratification and enhanced antimicrobial stewardship programs as these are critical for high-risk cancer patients.


  • Open Access

    A Distinct Clinical Entity of Invasive Cardiac Aspergillosis: Not the Heart Valves This Time

    by Zaid Al Khouri, Hunter Smeltzer, Anood Al Qura’an, Mohammad H. Khan, Alexandre E. Malek

    Invasive aspergillosis (IA) is a life-threatening infection that mainly affects immunocompromised hosts. Cardiac involvement is rare but can be the sole presentation of IA. It is associated with a high mortality rate and mostly occurs in patients with pre-existing cardiac disease. It can also be seen in immunocompetent patients with a structurally normal heart. The reported cases of cardiac involvement are usually due to infectious endocarditis (IE) caused by Aspergillus species (most commonly Aspergillus fumigatus). However, there is limited data on non-valvular cardiac aspergillosis (NVCA). We reviewed 67 cases of NVCA published between 1950–2024 and reported an additional case from our institution involving a 48-year-old female with kyphoscoliosis diagnosed with Aspergillus pericarditis.